Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹273 Cr₹205 Cr₹84 Cr₹57 Cr₹24 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹273 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹273 Cr
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr
Mar2021₹24 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹273 Cr
33.00
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr
140.72
Mar2021 ₹24 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,701.4 Cr 0.4% 5.5% -42% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,412.0 Cr -0.4% 6.4% 4.2% Stock Analytics
DIVIS LABORATORIES ₹170,343.0 Cr -1.5% -4.9% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,191.0 Cr -0.7% 4.8% 16.6% Stock Analytics
CIPLA ₹122,511.0 Cr -0.5% 1% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹106,523.0 Cr 2.2% 6.6% 5.7% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

0.4%

5.5%

-42%

SENSEX

0.7%

0.9%

6.1%


You may also like the below Video Courses